Do peptides actually work? Experts Explain
About this video
Gillett and O’Hara push back against clinicians who, they argue, dismiss all peptides as ineffective. They contend the category is too broad for one verdict, pointing to peptides that became approved medicines and to compounds they say have mechanistic and human safety data but no large randomized trials. Much of the video is a policy argument: Gillett advocates pharmacy-compounded sourcing over unregulated research-chemical sellers, criticizes the current regulatory category system, and compares the situation to prohibition creating a gray market. They acknowledge results are variable and reject miracle-cure marketing, framing their own approach as weighing mechanism, human data, approval status, patient context, and cancer-risk caution case by case.
Key takeaways
- Judge peptides individually, not as a single all-or-nothing category, the hosts argue
- Separate pharmacy-compounded products from unregulated research-chemical sellers
- Absence of a large trial is not identical to evidence of no effect, Gillett contends
- Expect variable results and be wary of Wolverine-style healing claims
- Regulatory and patent incentives shape which compounds ever get studied
Episode details: published February 26, 2026 · 967 views · 15:12 long. Summary written by Self Growth Videos from the episode itself. The hormone, metabolic and peptide concepts described are Dr. Kyle Gillett’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: Gillett Health is a clinical practice that treats these conditions.
← Previous: Is this the BEST weight loss peptide? · Next: Is this the best peptide stack? →
All Dr. Kyle Gillett videos · Dr. Kyle Gillett profile · Gillett Health (official site)
